Lamtidine
| Code | Size | Price |
|---|
| TAR-T32552-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Lamtidine is a biochemical.
CAS:
73278-54-3
Formula:
C18H28N6O
Molecular Weight:
344.463
Purity:
0.98
SMILES:
Cn1nc(N)nc1NCCCOc1cccc(CN2CCCCC2)c1
References
1. Sorba G, Bertinaria M, Di Stilo A, Gasco A, Scaltrito MM, Brenciaglia MI, Dubini F. Anti-Helicobacter pylori agents endowed with H2-antagonist properties. Bioorg Med Chem Lett. 2001 Feb 12;11(3):403-6. PubMed PMID: 11212121.
2. Coruzzi G, Adami M, Morini G, Pozzoli C, Cena C, Bertinaria M, Gasco A. Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties. J Physiol Paris. 2000 Jan-Feb;94(1):5-10. PubMed PMID: 10761682.
3. Sorba G, Gasco A, Coruzzi G, Adami M, Pozzoli C, Morini G, Bertaccini G. Mixed antisecretory and gastroprotective activities of a new H2-antagonist containing a nitric oxide-donor furoxan moiety. Arzneimittelforschung. 1997 Jul;47(7):849-54. PubMed PMID: 9272244.
4. Le Gros G, Zhang XM, Parsons PG. Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands. Melanoma Res. 1994 Dec;4(6):359-64. PubMed PMID: 7535606.